Facebook Pixel Code
x
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Medication nonadherence with type 2 diabetes

This is a preview of the 8-page document
Read full text
The capacity to account for or predict non-adherence with understood risk-aspects is still poor despite the discovery of an immense variety of substantial adherence predictors. During the first three years of treating type 2 diabetes, researchers have observed medication non-adherence driven by three special patterns (García-Pérez, Álvarez, Dilla, Gil-Guillén, and Orozco-Beltrán, 2013). The patterns are prime non-adherence, non-persistence, and noncompliance or poor administration. Prime non-adherence entails patients who get a prescription but at no time get the actual medicine. For type 2 antidiabetic medications, the occurrence of prime non-adherence ranges from 4% to 31% although troublesome symptoms would be likely for patients who do not get sugar-lowering medicine (Harrison and Lingvay, 2013).Medication non-adherence for type 2 diabetes is very high in both intervention and control sets, making it hard for researchers to evaluate the performance of certain nursing approaches (Joanna Briggs Institute, 2011). Researchers are conducting studies on continuation visits aimed at improving medication adherence for type 2 diabetes patients, frequently with little coordination to the real prescribing doctor. Physicians and pharmacists cannot inhibit medication non-adherence for type 2 diabetes if the healthcare system removes medicine costs for patients fully (Blackburn et al. Adherence to medication has many potential contributing factors. As a result, removing one barrier, even a factor as vital as cost, is not a solution to medical non-adherence amongst type 2 diabetes patients (Salas, Hughes, Zuluaga, Vardeva, and Lebmeier, 2009). In addition, small developments to a myriad of medicines might have significant decreases in morbidity related to type 2 diabetes.Two medication regimens that can manage type 2 diabetes are basal or background insulin dosage and basal-bolus regimens. To cater to overnight insulin needs, a pharmacist prescribes the basal or background insulin dosage as an intermediate regimen for type 2 diabetes (Sharma et al. Physicians largely prescribe this regimen together with short-term insulin injections to provide better adaptability. This regimen is widely used when the pharmacist decides to use intensified insulin medication to ensure optimum glycemic control. As a regimen, patients
This is a preview of the 8-page document
Open full text

Related Topics

Close ✕
Tracy Smith Editor&Proofreader
Expert in: Nursing, Medical science, Health Sciences & Medicine
Hire an Editor
Matt Hamilton Writer
Expert in: Nursing, Health Sciences & Medicine, Medical science
Hire a Writer
preview essay on Medication nonadherence with type 2 diabetes
  • Pages: 8 (2000 words)
  • Document Type: Essay
  • Subject: Nursing
  • Level: Ph.D.
WE CAN HELP TO FIND AN ESSAYDidn't find an essay?

Please type your essay title, choose your document type, enter your email and we send you essay samples

Contact Us